Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells

Chung Pu Wu*, Yen Ching Li, Megumi Murakami, Sung Han Hsiao, Yun Chieh Lee, Yang Hui Huang, Yu Tzu Chang, Tai Ho Hung, Yu Shan Wu, Suresh V. Ambudkar*

*此作品的通信作者

研究成果: 期刊稿件 › 文章 › 同行評審

3 引文 斯高帕斯（Scopus）

指紋

深入研究「Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells」主題。共同形成了獨特的指紋。

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science